Video Transcript
Kevin Marsh
Good evening ladies and gentlemen. Thank you very much. It's great to see so many people here. We weren't sure how many people would come to this malaria day. It's fantastic!
Today, we want to talk about the current malaria situation and give a sort of snapshot of some of the work that goes on in Oxford and through Oxford on malaria.
I'm just going to show a couple of slides at the beginning to orientate us.
I presume that most people here understand that malaria is a parasitic disease spread by mosquitoes.
We often say it's a global problem, and it is a global problem. But that actually doesn't quite get the picture because if you take into account where the people are and the parasites are, this is what malaria looks like on a map. In Africa, it's a massive problem, and in Asia, particularly South Asia, it's a massive problem, and that's because the population is so large. This is a global problem, but it's not an equally distributed global problem.
Had we been having this meeting 15-16 years ago, we'd have all been terribly depressed. Many of us were terribly depressed, and we were writing articles saying that malaria was a complete disaster. And it was a disaster - it was essentially out of control. Nobody had any real sense of what to do about it; there were massive drug resistance problems, and mortality was very high. Nobody knew how many; we used to make the numbers up. But there was an absolute lack apparently of international or national will to do anything about it.
Over the last 15 years, there's been a really remarkable change. I think the change was just a surprise. It more than pleasantly surprised many of us who work in malaria because often people talk about international initiatives and such like and usually not very much comes up.
In the case of malaria, there has been a real revolution over the last 15 years. And it's partly reflected in this figure; we show global spending on malaria control. At the beginning of this century, the whole world spent only a couple of a hundred million dollars a year on malaria control. Very quickly, after a series of concerted initiatives, this rose tenfold and has now gone up to about fiftyfold. So a really massive investment in malaria control around the world. You would hope that that would have some effect, and in fact, things have changed incredibly between 2000 and 2015.
People are used to looking at these maps, so if you're not, you'll see a lot more, I think from Katherine. You get a general idea that red is bad and blue is better. So you can see over 15 years looking at Africa alone, there's been a major change, as you can just see without going down into detail in the amount of malaria in Africa. But globally, over that period, over 600 million cases have been averted compared with the numbers in 2000. And really, I think extraordinarily global malaria mortality rates have fallen by an estimated 60%, and in Africa, probably somewhat more than that.
Now, if you had asked any of us at the beginning of the century how likely this was, I don't think many of us would have put very much on this. So it looks as if everything is great. Things are good to a degree, but there are some big issues on the horizon. Firstly, drug resistance, and you're going to hear quite a lot about that - both the situation and what can be done about it - secondly, funding. It's fantastic that funding has gone up fifteenfold, but it needs to go up thirtyfold, and if it doesn't, we'll stall, and things will return to where they were. So things aren't totally rosy. In fact, what's a very interesting point in history where many people are talking about elimination and even eradication. I think everyone should aim at eradication, but everyone should be more than aiming at being realistic. Unless we solve the problems of drug resistance, insecticide resistance and funding, there's no point in talking about any of these things. And one of the key things we need is new interventions. So you'll hear quite a lot today about potential new interventions both in terms of vaccines and also the power of genomics science to contribute to our understanding of malaria. So I'm going to introduce first Katherine Battle, who is going to talk about mapping, and I should have said that we talk about malaria as if it is a single thing. Of course, many of you will know it's not – there are several species, and we tend to talk about Africa. We tend to talk about falciparum because that's important. Still, there is another massively important malaria parasite, and just to bring the changes, Katherine is going to concentrate on that.
- NDM Strategic
- Contact
- Public Involvement
-
News
- Using management thinking to fight the superbug crisis
- Getting rid of malaria possible, if we try something new, say experts
- Success for NDM project awarded Public Engagement Seed Funding
- Flu vaccine spinout secures a further £20m in funding
- Global health needs demand new approach to drug discovery
- Building international partnerships to tackle disease
- Nepali pilgrims to Gosaikunda video
- China Vice Premier in Oxford for signing of research collaboration
- Largest genetic study of mosquitoes reveals spread of insecticide resistance across Africa
- Researchers attack Mekong malaria superbug on multiple fronts
- Kevin Marsh Wins 2017 Drexel Prize in Infectious Disease
- Prof Simon Leedham wins CRUK Prize
- Oxford-Mahidol collaboration shortlisted for Newton Prize
- Study raises possibility of vaccines against allergies and Alzheimer’s
- Celebrating Oxfordshire brightest science stars
- New structural insights accelerate drug discovery in the ubiquitin system for cancer therapy
- National Academy of Medicine elects Nick White as international member
- New collaboration to tackle superbugs
- 115 years of malaria in Africa
- Oxford and the mosquito
- World-first trial for universal flu vaccine
- New typhoid vaccine offers hope of protection for children
- Prof Emily Chan wins the 2017 UGC Teaching Award
- The Medical Research Foundation to fund first national PhD Training Programme to tackle antimicrobial resistance
- Superbug’s spread to Vietnam threatens malaria control
- Establishing the Africa Oxford Initiative
- Experts urge rethink of ‘outdated’ asthma categorisation
- International research network nominated for ‘Oscar of higher education’
- Oxford University claims top world ranking for second year
- Bash the Bug! Winner of 2017 NIHR Let’s Get Digital competition
- Scientists discover unknown virus in ‘throwaway’ DNA
- Improved home designs may fight malaria in Africa
- Antibodies may reveal timing of previous influenza infection
- Is it time to drop the ‘complete the course’ message for antibiotics?
- Quick test can predict anaemia in malaria patients treated with artemisinins
- Cancer hijacks natural cell process to survive
- Mahidol begins Asia’s first study of RTS,S malaria vaccine
- Oxford one of six sites to receive funding for health data science
- Five surprising things DNA has revealed about our ancestors
- OUMNH Exhibition based on centre research
- Could aspirin be used to treat tuberculous meningitis?
- ALS Reproducible Antibody Platform launched
- Cultural barriers to tackling the superbug crisis
- ALERRT epidemic research network launched in sub-Saharan Africa
- Making malaria visible
- Women in STM
- Female body shape gene may increase risk of type 2 diabetes
- The town that breeds resistance to Malaria drugs
- Can you cure HIV?
- Professor Dominic Kwiatkowski joins the Fellowship of the Royal Society
- Prof Vincenzo Cerundolo elected Fellow of the Royal Society
- NDM Researchers elected as Fellows of the Academy of Medical Science
- Using management thinking to fight the superbug crisis
- FORMA Therapeutics and the University of Oxford Announce Multi-Year Cross-Border Collaboration
- HIV researchers create Chelsea garden to raise awareness of disease stigma
- China Vice Premier and Minster of National Health Commission visit to CTI Beijing
- Oxford overtakes Cambridge for first time in QS world rankings
- New age-based regimen for single low-dose primaquine to block malaria transmission
- Rosalind Franklin Institute will 'transform' life sciences research through disruptive technologies
- Big Data Institute wins a 2018 RIBA South Award
- NDM Researcher gets £1m boost to study immunology of asthma
- Professor Rose McGready awarded Alumni Award for Service to Humanity
- Researchers explore malaria vaccines and antibiotic resistance at RS Summer Science Exhibition
- Trial of ‘kick and kill’ approach to HIV cure leaves puzzles to be solved
- NDM Researcher recognised for major contribution in clinical sciences
- ASHG Honours Professor Cecilia Lindgren with Mentorship Award
- New NDM Professors
- Prof Helen McShane appointed as new Director of Oxford Biomedical Research Centre
- Detailed map of colon cells in health and disease
- UK-led study marks shift towards genetic era in tackling TB
- Tales of treatment, of modernity and tradition, and of global health crisis
- Faith Osier TED talk
- 'Tantalising and exciting’: UK Biobank genetics opens the door to a new era of health research
- Oxford secures £17.5 million to lead national programmes in AI to improve healthcare
- New grant to study the role of immune cells in lung regeneration
- Dr Ross Chapman welcomed as EMBO Young Investigator
- New vaccines centre to protect UK from pandemic threats
- Professor Sir David Weatherall: 1933-2018
- Congratulations to Jeremy Farrar, knighted in the New Year's Honours 2019
- Watch Prof Peter Donnelly speak at Royal Society AI event
- NDM's Translational Gastroenterology Unit awarded a CRUK Primer grant of £100,000
- ISARIC awarded £4.5 million to tackle the global threat of epidemic infectious diseases
- Tracking resistance results presented at Westminster
- The battle within- new animation on the immune system
- Vaccine developed to treat osteoarthritic pain
- World Malaria Day 2019
- Faces of malaria
- Mads Gyrd-Hansen awarded Wellcome Trust Senior Research Fellowship renewal
- NDM Researchers elected Fellows of the Academy of Medical Sciences
- Oxford academics recognised in 2019 Queen’s Birthday Honours
- Ross Chapman awarded 2019 Lister Prize
- New maps could show how to beat malaria
- Vice-Chancellor’s Choice Award for Public Engagement with Research
- New malaria parasite mutations cause alarming antimalarial drug failures in Southeast Asia
- New NDM Professors
- Woman of the Future award for Science
- Medical Sciences and climate breakdown: time to move beyond evidence
- Oxford Tropical Medicine awarded two RSTMH medals
- Landmark partnership announced for development of COVID-19 vaccine
- Chan Zuckerberg Initiative awards funding to Oxford team to support inflammation research
- Oxford University Coronavirus Research Webinar
- New study reveals Oxford coronavirus vaccine produces strong immune response
- The Duke of Cambridge visits Oxford Vaccine Centre
- The Ludwig Institute for Cancer Research welcomes cancer epigenetics researcher Yang Shi
- New NDM titles awarded
- Future of Oxford professorship in vaccinology secured with £3.5 million gift
- Oxford study suggests notable decline in coronavirus cases and R rate on Isle of Wight after launch of the test and trace programme
- Dave Stuart awarded The Gabor Medal 2020
- Latest version of COVID-19 contact tracing app ready for testing on the Isle of Wight and Newham, London
- Collaboration with Magdalen College outreach to run remote work experience
- Persistent immune memory of COVID-19 found in recovered patient T cells
- New research shows tracing apps can save lives at all levels of uptake
- Evaluation of LamPORE rapid tests for Covid-19 show high levels of diagnostic sensitivity
- Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
- Oxford’s OpenABM-Covid19 mathematical model helps to control the coronavirus epidemic
- Oxford’s OpenABM-Covid19 mathematical model helps to control the coronavirus epidemic
- The University of Oxford and King Abdulaziz University (KAU) have partnered to create a new Centre for Artificial Intelligence and Precision Medicine.
- Professor Sarah Walker, a Professor of Medical Statistics and Epidemiology in NDM and the Oxford BRC’s Co-theme Lead for Antimicrobial Resistance and Modernising Microbiology, is to receive an OBE.
- Simon Leedham appointed as Professor of Molecular and Population Genetics
- Two vital research programmes taking place at the university of Oxford may hold the key to understanding the immunity of recovered Covid-19 patients.
- New partnership with The Alan Turing Institute and Royal Statistical Society to support Joint Biosecurity Centre COVID-19 response
- NDM’s Jenner Institute appoints first Bvlgari Scholars
- NDM New Professors
- Trials of Oxford coronavirus vaccine begin in Kenya
- Oxford ramps up COVID-19 testing capability
- Oxford’s vaccine research and development boosted by donation from Wafic Saïd
- Oxfordshire Young Scientists of the Year 2020
- Oxford University breakthrough on global COVID-19 vaccine
- First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
- Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on azithromycin, 14 December 2020
- National COVID-19 Infections Survey reveals changes to pandemic over time
- Professor Susie Dunachie awarded flagship NIHR career development award
- Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine
- Professor Sir Dave Stuart, FRS FMedSci knighted in New Year's Honours
- National consortium to study threats of new SARS-CoV-2 variants
- Lateral flow devices detect most infectious COVID-19 cases and could allow a safer relaxation of the current lockdown
- Oxford Cancer Centre appoints Professor Tim Elliot as new co-director
- Infectious disease experts estimate that using the NHS COVID-19 contact tracing app averted between 200,000 and 900,000 infections
- Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests
- Tocilizumab reduces deaths in patients hospitalised with COVID-19
- World’s largest clinical trial for COVID-19 treatments expands internationally
- Graduate access programmes now open for 2021 applications
- Professor Sarah Gilbert awarded RSA Albert Medal
- Professor Cecilia Lindgren appointed Director of the Big Data Institute
- USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
- The RECOVERY Trial: One year on
- Oxford University researchers release cheap, quick COVID-19 antibody test
- CCOUC Webinar on Health-EDRM Education and Research in China: Commemorating the 512 Wenchuan Earthquake
- National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines
- Director of NDM's Jenner Institute elected to The Royal Society
- Five new Academy of Medical Sciences Fellows from NDM
- Oxford University and Oracle partner to speed identification of COVID-19 variants
- RECOVERY trial named David Sackett Trial of the Year 2020
- University of Oxford to launch Pandemic Sciences Centre
- NDM Researchers recognised in Queen’s Birthday Honours
- RECOVERY Trial identifies another effective COVID-19 treatment
- Daily contact COVID-19 testing for students effective at controlling transmission in schools
- African trial of novel HIV vaccine candidate starts
- NDM New Associate Professors
- New NDM Professors
- Information Governance